Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by University Health Network, Toronto.
Recruitment status was  Recruiting
Study NCT00384410   Information provided by University Health Network, Toronto

First Received on October 4, 2006.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Insomnia
Additional conditions recognized in this trial
Sleep Initiation and Maintenance Disorders
More general conditions related to this trial
Dyssomnias
Mental Disorders
Nervous System Diseases
Sleep Disorders
Sleep Disorders, Intrinsic
Interventions listed in this trial
Nabilone
More general drug interventions related to this trial
Anti-Anxiety Agents
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Gastrointestinal Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University Health Network, Toronto
Valeant Pharmaceuticals International, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services